Sheila Fuller Sfuller at
Tue Sep 19 15:38:33 EST 2000

I have a question about billing for the technical component on leukemia/lymphoma
workups. The state of the art in gating strategy requires the use of multiple aliquots
of the same antibody. What is the standard practice for billing for these duplicate
aliquots of antibody?

More information about the Cytometry mailing list